Disclosures for "Real-World Effectiveness of Fremanezumab in Patients with Migraine who Switched From Another mAb Targeting the CGRP Pathway (Subgroup Analysis From FINESSE)")
-
Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. The institution of Andreas Straube has received research support from German research Counci (BMBF).
-
Gregor Broessner has received personal compensation for serving as an employee of Novartis. Gregor Broessner has received personal compensation for serving as an employee of TEVA. Gregor Broessner has received personal compensation for serving as an employee of Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
-
Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Weber & Weber, Lundbeck, and Perfood. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Sanofi-Aventis, Perfood, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Journal of Headache and Pain, Acta Neurologica Scandinavia. Dr. Gaul has received publishing royalties from a publication relating to health care. Dr. Gaul has received personal compensation in the range of $0-$499 for serving as a Honorary secretary with German Migraine and Headache Society.
-
Dr. Hamann has received personal compensation for serving as an employee of Teva GmbH.
-
Dr. Hipp has received personal compensation for serving as an employee of Teva.
-
Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
-
Dr. Schauerte has stock in Institut Dr. Schauerte GbR. Dr. Schauerte has received personal compensation in the range of $100,000-$499,999 for serving as a COO with Institut Dr. Schauerte GmbH.
-
Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Lilly, TEVA, Hormosan. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Lilly, TEVA, BIAL, Hormosan, Allergan.